{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:38:47Z","timestamp":1790617127025,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.cjca.2014.08.016","type":"journal-article","created":{"date-parts":[[2014,8,23]],"date-time":"2014-08-23T14:18:05Z","timestamp":1408803485000},"page":"1706-1715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["Hydroxychloroquine-Induced Cardiomyopathy: Case Report, Pathophysiology, Diagnosis, and Treatment"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2697-026X","authenticated-orcid":false,"given":"Haran","family":"Yogasundaram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan N.","family":"Putko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Ian","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibiana","family":"Cujec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Ringrose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin Y.","family":"Oudit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2014.08.016_bib1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.cjca.2014.04.029","article-title":"Chemotherapy-induced cardiotoxicity: detection, prevention, and management","volume":"30","author":"Truong","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2014.08.016_bib2","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","article-title":"Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management","volume":"53","author":"Yeh","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.08.016_bib3","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJM199412083312307","article-title":"Idiopathic dilated cardiomyopathy","volume":"331","author":"Dec","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.08.016_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0002-9343(83)91264-0","article-title":"Pharmacologic actions of 4-aminoquinoline compounds","volume":"75","author":"Mackenzie","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.cjca.2014.08.016_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/355167a0","article-title":"Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites","volume":"355","author":"Slater","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.cjca.2014.08.016_bib6","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cjca.2014.08.016_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.2008.101766","article-title":"Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review","volume":"69","author":"Ruiz-Irastorza","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cjca.2014.08.016_bib8","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1445-5994.2012.02886.x","article-title":"Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects","volume":"42","author":"Tang","year":"2012","journal-title":"Intern Med J"},{"key":"10.1016\/j.cjca.2014.08.016_bib9","doi-asserted-by":"crossref","first-page":"11865","DOI":"10.1073\/pnas.93.21.11865","article-title":"On the molecular mechanism of chloroquine's antimalarial action","volume":"93","author":"Sullivan","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjca.2014.08.016_bib10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/BOR.0b013e32834456bf","article-title":"Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action","volume":"23","author":"Katz","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.cjca.2014.08.016_bib11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0049-0172(10)80012-5","article-title":"Mechanism of action of hydroxychloroquine as an antirheumatic drug","volume":"23","author":"Fox","year":"1993","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.cjca.2014.08.016_bib12","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/europace\/eut290","article-title":"Evidence for cardiac safety and antiarrhythmic potential of chloroquine in systemic lupus erythematosus","volume":"16","author":"Teixeira","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2014.08.016_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1756-185X.2011.01630.x","article-title":"Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity","volume":"14","author":"Hassan","year":"2011","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.cjca.2014.08.016_bib14","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.08.016_bib15","doi-asserted-by":"crossref","unstructured":"Putko BN, Wen K, Thompson RB, et\u00a0al. Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment [e-pub ahead of print]. Heart Fail Rev http:\/\/dx.doi.org\/10.1007\/s10741-014-9452-9, accessed August 8, 2014.","DOI":"10.1007\/s10741-014-9452-9"},{"key":"10.1016\/j.cjca.2014.08.016_bib16","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0161-6420(02)01168-5","article-title":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report\u00a0by the American Academy of Ophthalmology","volume":"109","author":"Marmor","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.cjca.2014.08.016_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/archophthalmol.2010.321","article-title":"Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy","volume":"129","author":"Michaelides","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.cjca.2014.08.016_bib18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/acr.20133","article-title":"Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.cjca.2014.08.016_bib19","first-page":"501","article-title":"Chloroquine Neuromyopathy","volume":"38","author":"Whisnant","year":"1963","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"10.1016\/j.cjca.2014.08.016_bib20","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1378\/chest.06-1146","article-title":"Hydroxychloroquine-induced toxic myopathy causing respiratory failure","volume":"131","author":"Siddiqui","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.cjca.2014.08.016_bib21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2165\/00003495-198224040-00003","article-title":"Adverse effects of drugs on muscle","volume":"24","author":"Mastaglia","year":"1982","journal-title":"Drugs"},{"key":"10.1016\/j.cjca.2014.08.016_bib22","first-page":"2927","article-title":"Hydroxychloroquine neuromyotoxicity","volume":"27","author":"Stein","year":"2000","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.cjca.2014.08.016_bib23","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0002-9343(87)90444-X","article-title":"Chloroquine neuromyotoxicity. Clinical and pathologic perspective","volume":"82","author":"Estes","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.cjca.2014.08.016_bib24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1056\/NEJM198701223160405","article-title":"Diagnosis of chloroquine cardiomyopathy by endomyocardial biopsy","volume":"316","author":"Ratliff","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.08.016_bib25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1054-8807(02)00118-7","article-title":"Chloroquine cardiotoxicity: clinicopathologic features in three patients and comparison with three patients with Fabry disease","volume":"11","author":"Roos","year":"2002","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.cjca.2014.08.016_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.echo.2004.09.029","article-title":"Chloroquine-induced cardiomyopathy-echocardiographic features","volume":"18","author":"Naqvi","year":"2005","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cjca.2014.08.016_bib27","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1161\/CIRCULATIONAHA.105.600627","article-title":"Images in cardiovascular medicine. Contrast-enhanced magnetic resonance imaging of a patient with chloroquine-induced cardiomyopathy confirmed by endomyocardial biopsy","volume":"114","author":"Reffelmann","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.08.016_bib28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jacc.2010.03.109","article-title":"Images in cardiology. Chloroquine-induced transition from dilated to restrictive cardiomyopathy","volume":"57","author":"Pieroni","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.08.016_bib29","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3899\/jrheum.110959","article-title":"Cardiomyopathy caused by long-term treatment with chloroquine: a rare disease, or a rare diagnosis?","volume":"39","author":"Tonnesmann","year":"2012","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.cjca.2014.08.016_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijcard.2012.03.112","article-title":"Inhibition of cardiomyocyte lysosomal activity in hydroxychloroquine cardiomyopathy","volume":"157","author":"Frustaci","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2014.08.016_bib31","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.jacc.2013.08.1644","article-title":"The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation","volume":"62","author":"Arbustini","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.08.016_bib32","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/08923973.2013.780078","article-title":"Chloroquine cardiomyopathy - a review of the literature","volume":"35","author":"Tonnesmann","year":"2013","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.cjca.2014.08.016_bib33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1126\/science.169.3942.289","article-title":"Plasmodium falciparum in owl monkeys: drug resistance and chloroquine binding capacity","volume":"169","author":"Fitch","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.cjca.2014.08.016_bib34","doi-asserted-by":"crossref","first-page":"766","DOI":"10.6061\/clinics\/2013(06)07","article-title":"Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients","volume":"68","author":"Silva","year":"2013","journal-title":"Clinics"},{"key":"10.1016\/j.cjca.2014.08.016_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/ar3264","article-title":"The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus","volume":"13","author":"Kahlenberg","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cjca.2014.08.016_bib36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00003088-199631040-00003","article-title":"Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements","volume":"31","author":"Ducharme","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cjca.2014.08.016_bib37","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2165\/00003088-199325050-00005","article-title":"Clinical pharmacokinetics of slow-acting antirheumatic drugs","volume":"25","author":"Tett","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cjca.2014.08.016_bib38","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1177\/0961203312462757","article-title":"Evidence for risk of cardiomyopathy with hydroxychloroquine","volume":"21","author":"Sumpter","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.cjca.2014.08.016_bib39","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/rheumatology\/kel402","article-title":"Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases","volume":"46","author":"Costedoat-Chalumeau","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.cjca.2014.08.016_bib40","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/bmj.1.6120.1109","article-title":"Complete heart-block due to chronic chloroquine toxicity managed with permanent pacemaker","volume":"1","author":"Edwards","year":"1978","journal-title":"Br Med J"},{"key":"10.1016\/j.cjca.2014.08.016_bib41","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3109\/08923973.2013.766801","article-title":"Chloroquine cardiotoxicity mimicking connective tissue disease heart involvement","volume":"35","author":"Vereckei","year":"2013","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.cjca.2014.08.016_bib42","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","article-title":"Drug-induced QT prolongation and torsades de pointes","volume":"89","author":"Yap","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2014.08.016_bib43","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/j.ijcard.2007.04.055","article-title":"Conduction disorder and QT prolongation secondary to long-term treatment with chloroquine","volume":"127","author":"Stas","year":"2008","journal-title":"Int J Cardiol"},{"issue":"suppl 4","key":"10.1016\/j.cjca.2014.08.016_bib44","doi-asserted-by":"crossref","first-page":"iv39","DOI":"10.1093\/rheumatology\/kel315","article-title":"Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases","volume":"45","author":"Seferovic","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.cjca.2014.08.016_bib45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1191\/096120301673172543","article-title":"Complete heart block in an adult with systemic lupus erythematosus and recent onset of hydroxychloroquine therapy","volume":"10","author":"Comin-Colet","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.cjca.2014.08.016_bib46","first-page":"1926","article-title":"High-grade atrioventricular heart-block in 2 adults with systemic lupus-erythematosus","volume":"18","author":"Martinezcosta","year":"1991","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.cjca.2014.08.016_bib47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/096120339400300213","article-title":"Complete heart block in an adult with systemic lupus erythematosus","volume":"3","author":"Fonseca","year":"1994","journal-title":"Lupus"},{"key":"10.1016\/j.cjca.2014.08.016_bib48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/art.1780340125","article-title":"Heart block in systemic lupus erythematosus complicated by pacemaker \u201cexit block\u201d","volume":"34","author":"Olken","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cjca.2014.08.016_bib49","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1191\/0961203306lu2345oa","article-title":"The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters","volume":"15","author":"Wozniacka","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.cjca.2014.08.016_bib50","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/clc.22047","article-title":"Arrhythmias in Fabry cardiomyopathy","volume":"35","author":"Acharya","year":"2012","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cjca.2014.08.016_bib51","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.88.2.785","article-title":"Images in cardiovascular medicine. Chloroquine-induced cardiomyopathy","volume":"88","author":"Ferrans","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.08.016_bib52","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/35022604","article-title":"Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)","volume":"406","author":"Nishino","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.cjca.2014.08.016_bib53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12016-010-8243-x","article-title":"Hydroxychloroquine: from malaria to autoimmunity","volume":"42","author":"Ben-Zvi","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.cjca.2014.08.016_bib54","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4070\/kcj.2010.40.11.604","article-title":"A\u00a0case of chloroquine-induced cardiomyopathy that presented as sick sinus syndrome","volume":"40","author":"Lee","year":"2010","journal-title":"Korean Circ J"},{"key":"10.1016\/j.cjca.2014.08.016_bib55","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0076-6879(08)04016-0","article-title":"Novel methods for measuring cardiac autophagy in\u00a0vivo","volume":"453","author":"Perry","year":"2009","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.cjca.2014.08.016_bib56","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/PAS.0b013e3182863fa8","article-title":"LC3 and p62 as diagnostic markers of drug-induced autophagic vacuolar cardiomyopathy: a study of 3 cases","volume":"37","author":"Daniels","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cjca.2014.08.016_bib57","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000114244","article-title":"Morphologic study of a neuromyopathy caused by prolonged chloroquine treatment","volume":"9","author":"Gerard","year":"1973","journal-title":"Eur Neurol"},{"key":"10.1016\/j.cjca.2014.08.016_bib58","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.humpath.2007.06.013","article-title":"New clinical and ultrastructural findings in hydroxychloroquine-induced cardiomyopathy\u2013a report of 2 cases","volume":"38","author":"Soong","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cjca.2014.08.016_bib59","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1177\/0961203313497116","article-title":"Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease","volume":"22","author":"Nandagudi","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.cjca.2014.08.016_bib60","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIRCULATIONAHA.106.660258","article-title":"Letter by Pieroni et\u00a0al regarding article, \u201cContrast-enhanced magnetic resonance imaging of a patient with chloroquine-induced cardiomyopathy confirmed by endomyocardial biopsy\u201d","volume":"115","author":"Pieroni","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.08.016_bib61","doi-asserted-by":"crossref","first-page":"7","DOI":"10.14503\/THIJ-13-3920","article-title":"Cardiac magnetic resonance imaging for the investigation of cardiovascular disorders. Part 1: current applications","volume":"41","author":"Goenka","year":"2014","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.cjca.2014.08.016_bib62","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCIMAGING.113.000482","article-title":"T(1) mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex","volume":"6","author":"Thompson","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2014.08.016_bib63","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/eurjhf\/hfs206","article-title":"Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure","volume":"15","author":"Yoshida","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2014.08.016_bib64","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/hrt.2008.161166","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease: a commentary on joint AHA\/ACC\/ESC guidelines","volume":"95","author":"Elliott","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2014.08.016_bib65","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/CIRCULATIONAHA.109.924167","article-title":"Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance","volume":"122","author":"Yilmaz","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.08.016_bib66","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.carpath.2011.10.001","article-title":"2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology","volume":"21","author":"Leone","year":"2012","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.cjca.2014.08.016_bib67","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.107.186093","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology","volume":"116","author":"Cooper","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.08.016_bib68","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/ard.2004.023200","article-title":"Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients","volume":"65","author":"Casado","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cjca.2014.08.016_bib69","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","article-title":"2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis","volume":"64","author":"Singh","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.cjca.2014.08.016_bib70","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/1529-0131(199909)42:9<1785::AID-ANR1>3.0.CO;2-#","article-title":"American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines","volume":"42","author":"Guidelines for referral and management of systemic lupus erythematosus in adults","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cjca.2014.08.016_bib71","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2014.08.016_bib72","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1473-3099(07)70187-1","article-title":"Cardiotoxicity of antimalarial drugs","volume":"7","author":"White","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cjca.2014.08.016_bib73","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.annder.2009.01.016","article-title":"Chloroquine cardiotoxicity in long-term lupus therapy in two patients [in French]","volume":"136","author":"Saussine","year":"2009","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.cjca.2014.08.016_bib74","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.amjmed.2010.11.031","article-title":"Chemical cardiomyopathies: the negative effects of medications and nonprescribed drugs on the heart","volume":"124","author":"Figueredo","year":"2011","journal-title":"Am J Med"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X14012847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X14012847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T03:18:52Z","timestamp":1565752732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X14012847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":74,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0828282X14012847"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2014.08.016","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxychloroquine-Induced Cardiomyopathy: Case Report, Pathophysiology, Diagnosis, and Treatment","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2014.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}